In Zhejiang Province, the Chinese medicine industry took the lead in obtaining the qualification of enterprise technology center recognized by the state, and in the same period, it was approved by the State Ministry of Human Resources and Social Security to establish a national postdoctoral research center, which is also the first national postdoctoral workstation approved by Chinese medicine enterprises in the province. In August, Kangbain launched Qianlekang brand strategy in an all-round way, which triggered Qianlekang's "Hurricane Action on August 28" and was named as one of the top ten marketing cases of China medicine in that year. Lekang Dabao was thoroughly remoulded, and Yuanbang Lekang Dabao Capsule was successfully listed. After four years of hard work, it has become the first brand of male health care products market in Zhejiang Province. In 2002
Zhejiang Institute of Modern Chinese Medicine and Natural Medicine, the first provincial private drug research institution, was established in Hangzhou. In June, the joint-stock company ranked 10 in the 20 12 national over-the-counter drug industry statistical ranking list, and ranked third in the Chinese patent medicine ranking list.
In July, Southern Institute of Pharmaceutical Economics published the list of "Top 20 1 1 China Pharmaceutical Industry 100", and Kang ranked 38th.
In August, the company won the title of "Top Ten Advanced Units in Zhejiang Private Enterprise Culture Construction";
In 65438+February, the company was selected as "Key Enterprise Research Institute" in Zhejiang Province; Kang Group was selected as "Top 50 Comprehensive Competitiveness of Private Enterprises in China"; On June+10 in 5438, the company won the "20 10 China Pharmaceutical Enterprise Social Responsibility Contribution Award";
In February, "Kang Ziqiang Scholarship" won the third "Zhejiang Charity Award"; In July, Kangbain was awarded "201KLOC-0/Top 20 Most Competitive Pharmaceutical Listed Companies in China"; The company won national honors such as "Key High-tech Enterprise of National Torch Program", "National Innovative Demonstration Enterprise", "National Patent Demonstration Enterprise" and "National Intellectual Property Pilot Unit of Enterprises and Institutions".
In April, the company won the "2009 China Pharmaceutical Corporate Social Responsibility Award";
In July, the company won the third prize of Science and Technology Award of China Pharmaceutical Association for the project of "separating effective components from pollen to inhibit prostate tumor growth and developing new drugs";
In September, Qianliekang Pulean Tablets won the quality certificate of "Green Industry Standard for Foreign Trade and Economic Cooperation of Medicinal Plants and Preparations"; In June, 1 1, the company was selected as a constituent stock of the newly released SSE 380 Index, and its value in the capital market was further recognized. The company won the title of "Top Ten Modern Brands of Chinese Medicine Enterprises" at the 20 10 Brand Summit of Chinese Medicine Industry;
65438+February, the company "20 10 China Pharmaceutical Enterprise Social Responsibility Special Contribution Award";
In June+February, 5438, Qianliekang Pulean Tablets, Tianbaoning Ginkgo biloba leaves, Kangenbei Changyanning Tablets and Zhenshiming Eye Drops were awarded the most popular drugs in urinary system, cardiovascular and cerebrovascular diseases, gastrointestinal tract and ophthalmology respectively. In June 5438+10, it was awarded the title of "China Self-medication Industry Development Outstanding Contribution Enterprise" by China OTC Pharmaceutical Association; In April, it was named "Top Ten Enterprises in Zhejiang Pharmaceutical Industry in 2008";
In August, the former Le Kang film (Pulean film) won the "Brand on the 2009 China Drug Brand List";
In April, it won the title of "Top Ten Enterprises in Zhejiang Pharmaceutical Industry in 2007"; In July, it was awarded the National Postdoctoral Workstation by the National Ministry of Human Resources and Social Security, which is the first Chinese medicine enterprise in Zhejiang Province.
1/kloc-0 was awarded the National Enterprise Technology Center by the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the General Administration of Customs and State Taxation Administration of The People's Republic of China in June. In May, it was the first national recognized Chinese medicine enterprise technology center in Zhejiang Province, and was listed as "Top Ten Enterprises in Zhejiang Pharmaceutical Industry in 2005".
At the end of 1969, the bee farm of the Revolutionary Committee of Chengguan Town, Lanxi County was founded by fourteen "Black Five" personnel.
From 1972 to 10, the bee farm was renamed as Lanxi county bee milk factory, and the first product-bee milk oral liquid was produced.
From 65438 to 0975, the bee milk factory in Lanxi County was transformed and renamed Yunshan Pharmaceutical Factory.
1In August, 982, Hu Jiqiang, who just graduated from Zhejiang Medical University, reported to Yunshan Pharmaceutical Factory.
1985, appointed Hu Jiqiang as the director of Yunshan pharmaceutical factory; The Qianliekang product developed and marketed by him won the third prize of national scientific and technological progress award, which pioneered the non-surgical treatment of prostate diseases in China.